High galectin-1 expression correlates with poor prognosis and is involved in epithelial ovarian cancer proliferation and invasion.

[1]  Y. Miao,et al.  Galectin-1 Secreted by Activated Stellate Cells in Pancreatic Ductal Adenocarcinoma Stroma Promotes Proliferation and Invasion of Pancreatic Cancer Cells: An In Vitro Study on the Microenvironment of Pancreatic Ductal Adenocarcinoma , 2011, Pancreas.

[2]  A. Koong,et al.  Molecular and Cellular Pathobiology Tumor Galectin-1 Mediates Tumor Growth and Metastasis through Regulation of T-cell Apoptosis , 2022 .

[3]  Hsiao-Chin Hong,et al.  Targeting Galectin-1 in Carcinoma-Associated Fibroblasts Inhibits Oral Squamous Cell Carcinoma Metastasis by Downregulating MCP-1/CCL2 Expression , 2011, Clinical Cancer Research.

[4]  R. Kiss,et al.  Molecular and Cellular Pathobiology Tumor Cells Secrete Galectin-1 to Enhance Endothelial Cell Activity , 2022 .

[5]  Luigi Tornillo,et al.  Galectin-1 and Its Involvement in Hepatocellular Carcinoma Aggressiveness , 2010, Molecular medicine.

[6]  K. Mayo,et al.  Inhibiting tumor growth by targeting tumor vasculature with galectin-1 antagonist anginex conjugated to the cytotoxic acylfulvene, 6-hydroxylpropylacylfulvene. , 2010, Bioconjugate chemistry.

[7]  Jeong-Won Lee,et al.  Phase II Study of Combination Chemotherapy with Etoposide and Ifosfamide in Patients with Heavily Pretreated Recurrent or Persistent Epithelial Ovarian Cancer , 2009, Journal of Korean medical science.

[8]  R. Versteeg,et al.  Galectin-1 is a major effector of TrkB-mediated neuroblastoma aggressiveness , 2009, Oncogene.

[9]  R. Kiss,et al.  Galectins and Gliomas , 2009, Brain pathology.

[10]  Hsiao-Chin Hong,et al.  Galectin-1-Mediated Tumor Invasion and Metastasis, Up-Regulated Matrix Metalloproteinase Expression, and Reorganized Actin Cytoskeletons , 2009, Molecular Cancer Research.

[11]  Hyung-Seok Kim,et al.  Role of galectin-1 in migration and invasion of human glioblastoma multiforme cell lines. , 2008, Journal of neurosurgery.

[12]  K. Mayo,et al.  Ovarian tumor growth regression using a combination of vascular targeting agents anginex or topomimetic 0118 and the chemotherapeutic irofulven. , 2008, Cancer letters.

[13]  G. Rabinovich,et al.  Galectins: structure, function and therapeutic potential , 2008, Expert Reviews in Molecular Medicine.

[14]  W. Chiang,et al.  Overexpression of galectin-1 at the tumor invasion front is associated with poor prognosis in early-stage oral squamous cell carcinoma. , 2008, Oral oncology.

[15]  A. Jemal,et al.  Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.

[16]  A. Griffioen,et al.  The galectin profile of the endothelium: altered expression and localization in activated and tumor endothelial cells. , 2008, The American journal of pathology.

[17]  G. Rabinovich,et al.  Galectin-1 as a potential therapeutic target in autoimmune disorders and cancer , 2008, Expert opinion on biological therapy.

[18]  A. Griffioen,et al.  Galectins in the tumor endothelium: opportunities for combined cancer therapy. , 2007, Blood.

[19]  R. Kiss,et al.  Galectins as modulators of tumor progression in head and neck squamous cell carcinomas , 2007, Head & neck.

[20]  E. Jung,et al.  Galectin‐1 expression in cancer‐associated stromal cells correlates tumor invasiveness and tumor progression in breast cancer , 2007, International journal of cancer.

[21]  M. F. Troncoso,et al.  Galectins: matricellular glycan-binding proteins linking cell adhesion, migration, and survival , 2007, Cellular and Molecular Life Sciences.

[22]  Ruud P. M. Dings,et al.  Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy , 2006, Proceedings of the National Academy of Sciences.

[23]  Raghu Kalluri,et al.  Fibroblasts in cancer , 2006, Nature Reviews Cancer.

[24]  Hans-Joachim Gabius,et al.  Prognostic Significance of Endogenous Adhesion/Growth-Regulatory Lectins in Lung Cancer , 2005, Oncology.

[25]  G. Rabinovich.  Galectin-1 as a potential cancer target , 2005, British Journal of Cancer.

[26]  Ruud P. M. Dings,et al.  Anti-tumor activity of the novel angiogenesis inhibitor anginex. , 2003, Cancer letters.

[27]  R. Kiss,et al.  Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting , 2003, Cancer.

[28]  A. Berchuck,et al.  Galectin-1 Accumulation in the Ovary Carcinoma Peritumoral Stroma Is Induced by Ovary Carcinoma Cells and Affects Both Cancer Cell Proliferation and Adhesion to Laminin-1 and Fibronectin , 2003, Laboratory Investigation.

[29]  R. Kiss,et al.  Evaluation of the efficiency of chemotherapy in in vivo orthotopic models of human glioma cells with and without 1p19q deletions and in C6 rat orthotopic allografts serving for the evaluation of surgery combined with chemotherapy , 2002, Cancer.

[30]  R. Kiss,et al.  Galectin‐1 Modulates Human Glioblastoma Cell Migration into the Brain Through Modifications to the Actin Cytoskeleton and Levels of Expression of Small GTPases , 2002, Journal of neuropathology and experimental neurology.

[31]  H. Friess,et al.  Comparative Analysis of Galectins in Primary Tumors and Tumor Metastasis in Human Pancreatic Cancer , 2001, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[32]  H. S. Struijker Boudier,et al.  Anginex, a designed peptide that inhibits angiogenesis. , 2001, The Biochemical journal.

[33]  V. Castronovo,et al.  Increased expression of galectin‐1 in carcinoma‐associated stroma predicts poor outcome in prostate carcinoma patients , 2001, The Journal of pathology.

[34]  K. Mishima,et al.  Expression of galectin‐1 mRNA correlates with the malignant potential of human gliomas and expression of antisense galectin‐1 inhibits the growth of 9 glioma cells , 2000, Journal of neuroscience research.

[35]  Ariel,et al.  Specific inhibition of T‐cell adhesion to extracellular matrix and proinflammatory cytokine secretion by human recombinant galectin‐1 , 1999, Immunology.

[36]  G. Benvenuto,et al.  Galectin‐1 and galectin‐3 expression in human bladder transitional‐cell carcinomas , 1999, International journal of cancer.

[37]  L. Baum,et al.  Apoptosis of T cells mediated by galectin-1 , 1995, Nature.

[38]  S. Barondes,et al.  Galectins. Structure and function of a large family of animal lectins. , 1994, The Journal of biological chemistry.

[39]  J Hirabayashi,et al.  The family of metazoan metal-independent beta-galactoside-binding lectins: structure, function and molecular evolution. , 1993, Glycobiology.

[40]  C. Decaestecker,et al.  Adhesion/growth-regulatory tissue lectin galectin-1 in relation to angiogenesis/lymphocyte infiltration and prognostic relevance of stromal up-regulation in laryngeal carcinomas. , 2009, Anticancer research.

[41]  Gabriel A. Rabinovich,et al.  Galectins as modulators of tumour progression , 2005, Nature Reviews Cancer.

[42]  Stefano Iacobelli,et al.  90K (Mac-2 BP) and galectins in tumor progression and metastasis , 2004, Glycoconjugate Journal.